Literature DB >> 33910890

Covid-19: One dose of vaccine cuts risk of passing on infection by as much as 50%, research shows.

Elisabeth Mahase1.   

Abstract

Entities:  

Year:  2021        PMID： 33910890     DOI： 10.1136/bmj.n1112

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  7 in total

1.  Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study.

Authors:  David Hillus; Tatjana Schwarz; Pinkus Tober-Lau; Kanika Vanshylla; Hana Hastor; Charlotte Thibeault; Stefanie Jentzsch; Elisa T Helbig; Lena J Lippert; Patricia Tscheak; Marie Luisa Schmidt; Johanna Riege; André Solarek; Christof von Kalle; Chantip Dang-Heine; Henning Gruell; Piotr Kopankiewicz; Norbert Suttorp; Christian Drosten; Harald Bias; Joachim Seybold; Florian Klein; Florian Kurth; Victor Max Corman; Leif Erik Sander
Journal:  Lancet Respir Med       Date:  2021-08-13       Impact factor: 30.700

2.  Detection of persistent SARS-CoV-2 IgG antibodies in oral mucosal fluid and upper respiratory tract specimens following COVID-19 mRNA vaccination.

Authors:  Aubree Mades; Prithivi Chellamathu; Noah Kojima; Lauren Lopez; Melanie A MacMullan; Nicholas Denny; Aaron N Angel; Marilisa Santacruz; Joseph G Casian; Matthew Brobeck; Nina Nirema; Jeffrey D Klausner; Frederick Turner; Vladimir I Slepnev; Albina Ibrayeva
Journal:  Sci Rep       Date:  2021-12-27       Impact factor: 4.379

3.  High class filtering facepiece (FFP) are fundamental and effective in protection of emergency health care workers: an observational cohort study in a German community.

Authors:  Martin Lier; Stefan Nessler; Christine Stadelmann; Meike Pressler; Leif Saager; Onnen Moerer; Markus Roessler; Konrad Meissner; Martin S Winkler
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2021-10-30       Impact factor: 2.953

Review 4.  Actions and attitudes on the immunized patients against SARS-CoV-2.

Authors:  P De Lucas Ramos; A García-Botella; A García-Lledó; J Gómez-Pavón; J González Del Castillo; T Hernández-Sampelayo; M C Martín-Delgado; F J Martín Sánchez; M Martínez-Sellés; J M Molero García; S Moreno Guillén; F J Rodríguez-Artalejo; J Ruiz-Galiana; R Cantón; E Bouza
Journal:  Rev Esp Quimioter       Date:  2021-10-21       Impact factor: 1.553

5.  BNT162b2, mRNA-1273, and Sputnik V Vaccines Induce Comparable Immune Responses on a Par With Severe Course of COVID-19.

Authors:  Anna Kaznadzey; Maria Tutukina; Tatiana Bessonova; Maria Kireeva; Ilya Mazo
Journal:  Front Immunol       Date:  2022-04-13       Impact factor: 8.786

6.  Are mega-events super spreaders of infectious diseases similar to COVID-19? A look into Tokyo 2020 Olympics and Paralympics to improve preparedness of next international events.

Authors:  Tamal Chowdhury; Hemal Chowdhury; Elza Bontempi; Mario Coccia; Hasan Masrur; Sadiq M Sait; Tomonobu Senjyu
Journal:  Environ Sci Pollut Res Int       Date:  2022-09-06       Impact factor: 5.190

7.  A Cost-Benefit Analysis of COVID-19 Vaccination in Catalonia.

Authors:  Francesc López; Martí Català; Clara Prats; Oriol Estrada; Irene Oliva; Núria Prat; Mar Isnard; Roser Vallès; Marc Vilar; Bonaventura Clotet; Josep Maria Argimon; Anna Aran; Jordi Ara
Journal:  Vaccines (Basel)       Date:  2021-12-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.